Last reviewed · How we verify

NCT04950049

The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation

Status unknown NA Last updated 6 July 2021
What this trial tests

NA trial testing Dexamethasone in Adverse Effect in 200 participants. Status unknown.

Timeline
15 July 2021
Primary endpoint
31 August 2021
31 August 2021

Quick facts

Lead sponsorGeneral Hospital of Ningxia Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment200
Start date15 July 2021
Primary completion31 August 2021
Estimated completion31 August 2021

Drugs / interventions tested

Conditions studied

Sponsor

General Hospital of Ningxia Medical University

Who can join

Adults 18 to 65, any sex, with Adverse Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the efficacy of dilution with glucose and prolonged injection time on dexamethasone 21-phosphate induced perineal irritation (include pian and pruritus).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of dilution with glucose and prolonged injection time on dexamethasone-induced perineal irritation - A randomized controlled trial.
    Zhang Y, Liang H, Huang L, Zheng J, et al · · 2022 · PMID 36237832 · DOI 10.1515/med-2022-0556

Verify or expand the search:

Other trials of Dexamethasone

Trials testing the same drug.

Other recruiting trials for Adverse Effect

Currently open trials in the same condition.

Other General Hospital of Ningxia Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04950049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing